DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Prolactinoma
Prolactinoma
Endocrine Pathology (537-577)
MDM2 Gene Polymorphisms May Be Associated with Tumor
Clinical Radiation Oncology Review
Multiple Endocrine Neoplasia Type 1 (MEN1)
Neoplastic Metastases to the Endocrine Glands
Pituitary Adenomas: from Diagnosis to Therapeutics
New Jersey State Cancer Registry List of Reportable Diseases and Conditions Effective Date March 10, 2011; Revised March 2019
Giant Prolactinoma Causing Hydrocephalus and Intracranial Hypertension As First Manifestations of Multiple Endocrine Neoplasia Type 1
Possible Functional Regression of Insulinoma with Prolonged Octreotide C E H Craig, I W Gallen
Endocrine Disorders for the USMLE, Step One
Prolactinoma As a Cause of Persistent Hyperprolactinemia in 6-Pyruvoyl-Tetrahydropterin Synthase Deficiency
2018 Solid Tumor Rules Lois Dickie, CTR, Carol Johnson, BS, CTR (Retired), Suzanne Adams, BS, CTR, Serban Negoita, MD, Phd
Prolactinoma in Some Ménière's Patients
Introduction Epidemiology
Clinical Testing for Multiple Endocrine Neoplasia Type 1 in a DNA Diagnostic Laboratory Roger D
Prolactinoma
NYS Cancer Registry Facility Reporting Manual
Pituitary Tumors Early Detection, Diagnosis, and Staging Detection and Diagnosis
Top View
Insulinoma in a Patient with MEN 1 Syndrome — 9-Year Follow-Up: Case Report Insulinoma U Pacjenta Z Zespołem MEN 1 — 9-Letnia Obserwacja: Opis Przypadku Klinicznego
Neuro-Psychiatric Manifestations In
Management of the Pregnant Patient with a Prolactinoma
Controversial Issues in the Management of Hyperprolactinemia and Prolactinomas – an Overview by the Neuroendocrinology Depart
Somatostatin Analogs in Clinical Practice: a Review
Prolactinoma
Metformin Induces Different Responses in Clear Cell Renal Cell Carcinoma Caki Cell Lines
Endocrine Surgery Korean J Endocrine Surg 2014;14:7-11
Bilateral Pituitary Adenomas Occurring with Multiple Endocrine Neoplasia Type One
Differences in Dopaminergic Regulation of PRL and Aldosterone Secretion
Case Report Symptomatic Pituitary Metastasis As Initial Manifestation of Renal Cell Carcinoma: Case Report and Review of Literature
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 1
Differentiated Thyroid Cancer Why Does It Affect Predominantly Women
Multiple Endocrine Neoplasia Syndromes Glenda G
An Unusual Presentation of a Patient with Multiple Endocrine Neoplasia- 1
Prolactinoma
Cervical Metastases of Glucagonoma in a Patient with Multiple Endocrine Neoplasia Type 1: Report of a Case
New Jersey State Cancer Registry List of Reportable Diseases and Conditions Revised June 2018
Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion
Prolactinoma
Natural Course of Small Adrenal Lesions in Multiple Endocrine
Case Report Who Were Those MEN Hiding Behind the Ulcers?: a Case Report
Treatment-Resistant Pediatric Giant Prolactinoma and Multiple
Multiple Endocrine Neoplasia Type 1: a Case Report with Review of Imaging Findings
Malignant Prolactinoma: Case Report and Review of the Literature
FOXP1-Induced Lncrna CLRN1-AS1 Acts As a Tumor Suppressor In
Endocrine and Neuroendocrine Tumors
Genetic Testing for Multiple Endocrine Neoplasia, Type 1 and 2
MEN1 Mutation Analysis in Chinese Patients with Multiple Endocrine Neoplasia Type 1
Endocrine Boston, MA
NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor
Multiple Endocrine Neoplasia Type 1 in Brazil
ABSITE REVIEW WEBINAR High Yield Review- Breast and Endocrine Topics
ICD - O International Classification of Diseases for Oncology International Classification of Diseases for Oncology
Common Tumors of the Pituitary and Thyroid: Pathology and Prognostic Implications
Multiple Endocrine Neoplasia Type 1
Prolactin-Producing Pituitary Carcinoma, Hypopituitarism, and Graves’ Disease—Report of a Challenging Case and Literature Review
Neuroendocrine Tumors
Neuroendocrine Tumours
Management of Giant Prolactinoma Causing Craniocervical Instability: Illustrative Case
Contraceptive Options for Women with Prolactinoma September 2012
Familial Multiple Endocrine Neoplasia, Type I, in Identical Twins